Dina Dahan
Neurology with Special Qualifications in Child Neurology · Orlando, FLNPI 1093806655
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,832 of the $4,883 with a category attached, or 78.5%. 27 manufacturers reported payments, led by Neuropace, Inc. at 32.7% of the total. Reporting peaked in 2019 at $2,147 and has fallen 73.7% since, to $565 in 2025.
Across 102 payments — averaging $47.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neuropace, Inc.$2K
- Sunovion Pharmaceuticals Inc.$426
- UCB, Inc.$401
- Eisai Inc.$305
- Supernus Pharmaceuticals, Inc.$295
- Greenwich Biosciences, Inc.$269
- plus $2K from 21 others
What the payments were for
- Travel & lodging$1,03821%
- Food & beverage$3,83278%
- Education$140%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neuropace, Inc. | 6 | $1,595 |
| Sunovion Pharmaceuticals Inc. | 9 | $426 |
| UCB, Inc. | 11 | $401 |
| Eisai Inc. | 6 | $305 |
| Supernus Pharmaceuticals, Inc. | 14 | $295 |
| Greenwich Biosciences, Inc. | 3 | $269 |
| AbbVie | 6 | $254 |
| Jazz Pharmaceuticals Inc. | 6 | $247 |
| Insightec,inc | 1 | $171 |
| Neurelis, Inc. | 7 | $139 |
| Biohaven Pharmaceuticals, Inc. | 1 | $131 |
| SK Life Science, Inc. | 6 | $127 |
| Sumitomo Pharma America, Inc. | 6 | $113 |
| Upsher-smith Laboratories LLC | 3 | $61 |
| Novartis | 3 | $57 |
| Otsuka America Pharmaceutical, Inc. | 2 | $43 |
| Livanova USA, Inc. | 1 | $31 |
| Aquestive Therapeutics, Inc. | 2 | $31 |
| AstraZeneca | 1 | $28 |
| Catalyst Pharmaceuticals, Inc. | 1 | $26 |
| Mallinckrodt Enterprises LLC | 1 | $22 |
| GE HealthCare | 1 | $22 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
| Biogen | 1 | $20 |
| Zogenix Inc. | 1 | $18 |
| Aucta Pharmaceuticals, Inc. | 1 | $16 |
| Amneal Pharmaceuticals LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RNS System$1,525
- Epidiolex$385
- APTIOM$246
- Fycompa$245
- Exablate$171
- NURTEC ODT$131
- BOTOX$126
- Briviact$124
How this compares
$4,883 in reported general payments places this provider in the 55th percentile of 137 neurology with special qualifications in child neurology providers in Florida.
See all neurology with special qualifications in child neurology providers in Florida →
Other neurology with special qualifications in child neurology in Orlando
- Omer Abdul HamidOrlando$283K
- Ngoc Minh leOrlando$19K
- Vikram PrakashOrlando$15K
- Ki-Hyeong LeeOrlando$15K
- Sheila Ramos MartinezOrlando$8K
- Anthony GiordanoOrlando$7K
- Murtuza KothawalaOrlando$5K
- Carl BarrOrlando$5K
- Antonio Vazquez-DiazOrlando$5K
- Paul WinnerWest Palm Beach$624K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.